Despite biochemical similarities with respect to accumulating metabolites and mechanisms, the phenotype of the ET patients is different from the homozygous (embryonic lethal) and heterozygous Pcyt2 mouse models. This evidence concerns the gene PCYT2 and essential thrombocythemia.